Status:
COMPLETED
Role of Gut Microbiome in the Health Benefits
Lead Sponsor:
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Conditions:
Normal Population
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Beneficial effects of moderate chronic consumption of beer have been extensively reported, however, the mechanisms have not been elucidated yet. Gut microbiota is an important mediator in the homeosta...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Usual consumer of Beer
Exclusion
- being a non usual beer-consumer,
- body mass index (BMI) \> 40 kg m2.
- acute or chronic infection, inflammatory disease or endocrine disorders; history of cancer; leukocytosis; anti-inflammatory, corticosteroid or hormone treatment.
- history of alcohol abuse or drug dependence.
- under a restrictive diet or a weight change ≥5 kg during the 3 months prior to the study.
- antibiotic therapy, prebiotics, probiotics, synbiotics, vitamin supplements or any other medical treatment influencing intestinal microbiota during the 3 months before the start of the study or during the study.
Key Trial Info
Start Date :
February 13 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05300165
Start Date
February 13 2019
End Date
December 30 2020
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Virgen de la Victoria
Málaga, Spain, 29010